|
|
Post by myocat on Jun 1, 2017 12:09:52 GMT -5
|
|
|
|
Post by akemp3000 on Jun 1, 2017 12:27:24 GMT -5
Just have to note the first sentence, "Inhaled insulin first made an appearance on the US market in 2011...was withdrawn by Pfizer within a year". Pfizer actually took it off the market in October of 2006. Also, the "non-inferior" tag ridiculously and continually misrepresents the efficacy of Afrezza because it was based on antiquated testing protocols by the FDA at the time. Other than that, I agree it's great to see "AFREZZA" anywhere  |
|
|
|
Post by peppy on Jun 1, 2017 12:35:06 GMT -5
"Recently, Sanofi began marketing a new inhaled insulin known as Afrezza®. "
nuf said
|
|
|
|
Post by porkini on Jun 1, 2017 13:04:42 GMT -5
"Recently, Sanofi began marketing a new inhaled insulin known as Afrezza®. " nuf said I just used their "Contact Us" to let them know they listed the wrong company as marketing the product. |
|
|
|
Post by peppy on Jun 1, 2017 13:07:28 GMT -5
"Recently, Sanofi began marketing a new inhaled insulin known as Afrezza®. " nuf said I just used their "Contact Us" to let them know they listed the wrong company as marketing the product. This has to be an old rekindled article. no blank pages allowed, in need of content. it is trash
|
|
